Protein Immunovation is a preclinical-stage biotechnology company developing a groundbreaking oral immunotherapy for colon cancer. We combine Interleukin-15 (IL-15) and Interleukin-2 (IL-2) into a novel oral delivery platform that harnesses and amplifies the body’s own immune system — empowering it to fight cancer with the powerful tools it already possesses.

Our World-Class Team

A tightly integrated team of four leading scientists and innovators:

• The visionary researcher whose breakthrough idea and laboratory expertise launched the platform
• A molecular biologist and professor who also brings deep patent expertise
• An entrepreneur and chemist with sharp business acumen
• A highly accomplished pathologist with decades of clinical and diagnostic experience

Together, we are redefining cancer immunotherapy through elegant, patient-friendly oral delivery — making powerful cytokine therapy more accessible, convenient, and potentially transformative for colon cancer patients.